These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38847081)

  • 21. Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population.
    Lander BS; Zhao Y; Hasegawa K; Maurer MS; Tower-Rader A; Fifer MA; Reilly MP; Shimada YJ
    Front Cardiovasc Med; 2022; 9():839409. PubMed ID: 35783832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.
    Minami Y; Haruki S; Kanbayashi K; Maeda R; Itani R; Hagiwara N
    Heart Rhythm; 2018 Oct; 15(10):1484-1490. PubMed ID: 29709578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of natriuretic peptides and troponins in hypertrophic cardiomyopathy.
    Kehl DW; Buttan A; Siegel RJ; Rader F
    Int J Cardiol; 2016 Sep; 218():252-258. PubMed ID: 27236124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics.
    Guo L; Wang B; Zhang F; Gao C; Hu G; Zhou M; Wang R; Zhao H; Yan W; Zhang L; Ma Z; Yang W; Guo X; Huang C; Cui Z; Sun F; Song D; Liu L; Tao L
    Chin Med J (Engl); 2022 Aug; 135(16):1952-1961. PubMed ID: 36156511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
    Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
    J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
    Boleti OD; Roussos S; Norrish G; Field E; Oates S; Tollit J; Nepali G; Bhole V; Uzun O; Daubeney PEF; Stuart GA; Fernandes P; McLeod K; Ilina M; Liaqath MNA; Bharucha T; Delle Donne G; Brown E; Linter K; Khodaghalian B; Jones C; Searle J; Mathur S; Boyd N; Reindhardt Z; Duignan S; Prendiville T; Adwani S; Zenker M; Wolf CM; Kaski JP
    Int J Cardiol; 2023 Dec; 393():131405. PubMed ID: 37777071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
    Liang LW; Raita Y; Hasegawa K; Fifer MA; Maurer MS; Reilly MP; Shimada YJ
    Heart; 2022 Oct; 108(22):1807-1814. PubMed ID: 35351822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
    Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
    Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
    Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
    Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.
    Orenes-Piñero E; Hernández-Romero D; de Torre C; Vilchez JA; Martínez M; Romero-Aniorte AI; Climent V; García-Honrubia A; Valdés M; Marín F
    Ann Med; 2013 Jun; 45(4):341-7. PubMed ID: 23701180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.
    Hertzsch S; Roos A; Wess G
    J Vet Intern Med; 2019 May; 33(3):1242-1250. PubMed ID: 30990935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy.
    Sonnenschein K; Wilczek AL; de Gonzalo-Calvo D; Pfanne A; Derda AA; Zwadlo C; Bavendiek U; Bauersachs J; Fiedler J; Thum T
    Sci Rep; 2019 Dec; 9(1):20350. PubMed ID: 31889077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
    Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
    Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study.
    McGorrian CM; Lyster S; Roy A; Tarrant H; Codd M; Doran P; Fitzgibbon M; Galvin J; Mahon NG
    BMC Cardiovasc Disord; 2013 Sep; 13():70. PubMed ID: 24020864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.